Inorganic Nanoparticle-Loaded Exosomes for Biomedical Applications.
bioimaging
biomimetic nanocarriers
exosomes
inorganic nanoparticles
theranostics
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
20 Feb 2021
20 Feb 2021
Historique:
received:
29
12
2020
revised:
05
02
2021
accepted:
16
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
10
4
2021
Statut:
epublish
Résumé
Exosomes are intrinsic cell-derived membrane vesicles in the size range of 40-100 nm, serving as great biomimetic nanocarriers for biomedical applications. These nanocarriers are known to bypass biological barriers, such as the blood-brain barrier, with great potential in treating brain diseases. Exosomes are also shown to be closely associated with cancer metastasis, making them great candidates for tumor targeting. However, the clinical translation of exosomes are facing certain critical challenges, such as reproducible production and
Identifiants
pubmed: 33672706
pii: molecules26041135
doi: 10.3390/molecules26041135
pmc: PMC7924372
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Anal Chem. 2019 Oct 15;91(20):12752-12759
pubmed: 31529961
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1594
pubmed: 31840427
Nat Rev Immunol. 2002 Aug;2(8):569-79
pubmed: 12154376
Nanomedicine (Lond). 2020 Apr;15(9):913-926
pubmed: 32216580
ACS Nano. 2018 Nov 27;12(11):10817-10832
pubmed: 30346694
Anal Biochem. 2014 Mar 1;448:41-9
pubmed: 24333249
Int J Nanomedicine. 2017 Oct 27;12:7923-7936
pubmed: 29138559
J Am Chem Soc. 2016 Feb 17;138(6):1893-903
pubmed: 26804745
Theranostics. 2018 Jan 1;8(1):237-255
pubmed: 29290805
Nanomedicine (Lond). 2011 Jan;6(1):99-109
pubmed: 21182422
Biomaterials. 2018 Sep;177:139-148
pubmed: 29890363
J Control Release. 2020 Oct 10;326:599-614
pubmed: 32730952
J Mater Sci. 2016 Jan;51(1):513-553
pubmed: 26586919
Acta Pharmacol Sin. 2017 Jun;38(6):754-763
pubmed: 28392567
J Nanobiotechnology. 2019 Jan 25;17(1):16
pubmed: 30683120
Int J Mol Sci. 2013 Jul 31;14(8):15910-30
pubmed: 23912234
Nanoscale. 2019 Oct 28;11(40):18825-18836
pubmed: 31595912
Pharmaceutics. 2021 Jan 19;13(1):
pubmed: 33477972
Int J Nanomedicine. 2014 Mar 31;9:1641-53
pubmed: 24729700
Nanomedicine (Lond). 2020 May;15(11):1127-1145
pubmed: 32329396
J Cell Physiol. 2019 Dec;234(12):23097-23110
pubmed: 31124125
ACS Nano. 2016 Mar 22;10(3):3323-33
pubmed: 26938862
PLoS One. 2018 Jun 22;13(6):e0199438
pubmed: 29933408
ACS Nano. 2019 Feb 26;13(2):1499-1510
pubmed: 30677286
J Circ Biomark. 2015 Jul 17;4:7
pubmed: 28936243
BMC Cancer. 2018 Jan 6;18(1):47
pubmed: 29306323
ACS Nano. 2017 Nov 28;11(11):10883-10893
pubmed: 28960957
Cell Mol Bioeng. 2019 Dec 23;13(1):1-16
pubmed: 32030104
Nat Commun. 2019 Aug 23;10(1):3838
pubmed: 31444335
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Trends Mol Med. 2017 Jul;23(7):636-650
pubmed: 28648185
J Cell Physiol. 2019 Dec;234(12):21588-21600
pubmed: 31093975
Semin Cell Dev Biol. 2017 Jul;67:3-10
pubmed: 28077297
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Acta Pharm Sin B. 2016 Jul;6(4):287-96
pubmed: 27471669
Sci Adv. 2020 May 01;6(18):eaaz0952
pubmed: 32494669
J Mater Chem B. 2020 Apr 8;8(14):2845-2855
pubmed: 32175535
Magn Reson Med. 2015 Jul;74(1):266-271
pubmed: 25052384
Mol Cell Biochem. 2019 Dec;462(1-2):1-10
pubmed: 31468244
ACS Appl Nano Mater. 2020 Jul 24;3(7):7211-7222
pubmed: 34568770
Nano Lett. 2019 Jun 12;19(6):3422-3431
pubmed: 30761901
Biomaterials. 2019 Dec;224:119492
pubmed: 31557588
Sci Rep. 2019 Jun 4;9(1):8278
pubmed: 31164665
Int J Nanomedicine. 2016 Jun 01;11:2481-90
pubmed: 27330291
Int J Mol Sci. 2020 Jan 19;21(2):
pubmed: 31963931
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Semin Cancer Biol. 2017 Jun;44:170-181
pubmed: 28215970
J Nanobiotechnology. 2020 Jan 23;18(1):20
pubmed: 31973696
ACS Appl Mater Interfaces. 2014 Sep 10;6(17):15412-9
pubmed: 25144382